89 related articles for article (PubMed ID: 31053301)
21. Identification and characterization of novel ERBB4 variant associated with sporadic amyotrophic lateral sclerosis (ALS).
Kwon Y; Kang M; Jeon YM; Lee S; Lee HW; Park JS; Kim HJ
J Neurol Sci; 2024 Feb; 457():122885. PubMed ID: 38278691
[TBL] [Abstract][Full Text] [Related]
22. Analysis of regulatory mechanism after ErbB4 gene mutation based on local modeling methodology.
Chen CL; Zhao JW
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323039
[TBL] [Abstract][Full Text] [Related]
23. ErbB1 and ErbB4 generate opposing signals regulating mesenchymal cell proliferation during valvulogenesis.
Iwamoto R; Mine N; Mizushima H; Mekada E
J Cell Sci; 2017 Apr; 130(7):1321-1332. PubMed ID: 28232522
[TBL] [Abstract][Full Text] [Related]
24. Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
Bae JA; Kho DH; Sun EG; Ko YS; Yoon S; Lee KH; Ahn KY; Lee JH; Joo YE; Chung IJ; Lee SH; Kim H; Kim KK
Clin Cancer Res; 2016 Mar; 22(5):1284-94. PubMed ID: 26527747
[TBL] [Abstract][Full Text] [Related]
25. KITENIN functions as a fine regulator of ErbB4 expression level in colorectal cancer via protection of ErbB4 from E3-ligase Nrdp1-mediated degradation.
Sun EG; Lee KH; Ko YS; Choi HJ; Yang JI; Lee JH; Chung IJ; Paek YW; Kim H; Bae JA; Kim KK
Mol Carcinog; 2017 Mar; 56(3):1068-1081. PubMed ID: 27648936
[TBL] [Abstract][Full Text] [Related]
26. Developmental, neurochemical, and behavioral analyses of ErbB4 Cyt-1 knockout mice.
Erben L; Welday JP; Cronin ME; Murphy R; Skirzewski M; Vullhorst D; Carroll SL; Buonanno A
J Neurochem; 2022 Jun; 161(5):435-452. PubMed ID: 35523590
[TBL] [Abstract][Full Text] [Related]
27. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
[TBL] [Abstract][Full Text] [Related]
28. ERK-mediated phosphorylation of fibroblast growth factor receptor 1 on Ser777 inhibits signaling.
Zakrzewska M; Haugsten EM; Nadratowska-Wesolowska B; Oppelt A; Hausott B; Jin Y; Otlewski J; Wesche J; Wiedlocha A
Sci Signal; 2013 Feb; 6(262):ra11. PubMed ID: 23405013
[TBL] [Abstract][Full Text] [Related]
29. Identification of in vivo roles of ErbB4-JMa and its direct nuclear signaling using a novel isoform-specific knock out mouse.
Doherty R; MacLeod BL; Nelson MM; Ibrahim MMH; Borges BC; Jaradat NW; Finneran MC; Giger RJ; Corfas G
Sci Rep; 2022 Oct; 12(1):17267. PubMed ID: 36241655
[TBL] [Abstract][Full Text] [Related]
30. Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.
Wali VB; Haskins JW; Gilmore-Hebert M; Platt JT; Liu Z; Stern DF
Mol Cancer Res; 2014 Aug; 12(8):1140-55. PubMed ID: 24829397
[TBL] [Abstract][Full Text] [Related]
31. Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms.
Sundvall M; Korhonen A; Paatero I; Gaudio E; Melino G; Croce CM; Aqeilan RI; Elenius K
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4162-7. PubMed ID: 18334649
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines.
Gallo RM; Bryant I; Fry R; Williams EE; Riese DJ
Biochem Biophys Res Commun; 2006 Oct; 349(1):372-82. PubMed ID: 16934755
[TBL] [Abstract][Full Text] [Related]
33. ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein.
Chen SL; Lin ST; Tsai TC; Hsiao WC; Tsao YP
Oncogene; 2007 Jan; 26(1):42-53. PubMed ID: 16819515
[TBL] [Abstract][Full Text] [Related]
34. The 96 kDa protein kinase activated by oncogenic Ras in Xenopus egg extracts is also activated by constitutively active Mek: activation requires serine/threonine phosphorylation.
Pan BT; Zhang Y; Brott B; Chen DH
Oncogene; 1997 Apr; 14(14):1653-60. PubMed ID: 9135066
[TBL] [Abstract][Full Text] [Related]
35. ERBB4 mutation analysis: emerging molecular target for melanoma treatment.
Lau C; Killian KJ; Samuels Y; Rudloff U
Methods Mol Biol; 2014; 1102():461-80. PubMed ID: 24258993
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome.
Sapkota GP; Boudeau J; Deak M; Kieloch A; Morrice N; Alessi DR
Biochem J; 2002 Mar; 362(Pt 2):481-90. PubMed ID: 11853558
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase.
Balan V; Leicht DT; Zhu J; Balan K; Kaplun A; Singh-Gupta V; Qin J; Ruan H; Comb MJ; Tzivion G
Mol Biol Cell; 2006 Mar; 17(3):1141-53. PubMed ID: 16407412
[TBL] [Abstract][Full Text] [Related]
38. Role for tyrosine phosphorylation of SUV39H1 histone methyltransferase in enhanced trimethylation of histone H3K9 via neuregulin-1/ErbB4 nuclear signaling.
Nakajo H; Ishibashi K; Aoyama K; Kubota S; Hasegawa H; Yamaguchi N; Yamaguchi N
Biochem Biophys Res Commun; 2019 Apr; 511(4):765-771. PubMed ID: 30833073
[TBL] [Abstract][Full Text] [Related]
39. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester.
Elenius K; Corfas G; Paul S; Choi CJ; Rio C; Plowman GD; Klagsbrun M
J Biol Chem; 1997 Oct; 272(42):26761-8. PubMed ID: 9334263
[TBL] [Abstract][Full Text] [Related]
40. Selective cleavage of ErbB4 by G-protein-coupled gonadotropin-releasing hormone receptor in cultured hypothalamic neurons.
Higa-Nakamine S; Maeda N; Toku S; Yamamoto T; Yingyuenyong M; Kawahara M; Yamamoto H
J Cell Physiol; 2012 Jun; 227(6):2492-501. PubMed ID: 21898395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
